INZYInozyme Pharma Inc

$0.00
$0.00
(0.00%)
Today
Updated:
Reported EarningsMay 14
Mkt Cap$258.25M
Vol1.46M
News
all
press releases
News Placeholder
Biotech Stock Roundup: BMRN to Acquire INZY, NVAX Gains on Vaccine Approval & More
Zacks
News Placeholder
BioMarin Offers to Buy Inozyme for $270M to Boost Enzyme Therapy Biz
Zacks
News Placeholder
Inozyme Stock Rockets 179% After BioMarin Agrees To Acquire The Company For $270M: Retail Sentiment Brightens
The deal's per-share price consideration implies an 182% premium to Inozyme’s closing price of $1.42 on Thursday.
Stocktwits
<
...
1
>

Advertisement|Remove ads.